26-09-2025 12:56 Home | Feedback | Sitemap| Careers | Contact Us |FAQ | Investor Complaints Data | Investor Charter Stock-Broker | Investor DP
  You Are On:MUTUAL FUNDS
Mutual Fund
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activity
All Holding
Whats In / Out
MF Trends
MF Tools
Scheme Profile
AMC:  Category : Scheme :
Detailed Portfolio
Nippon India Pharma Fund(G)
TypeInvestment InPercentage of NAVNo. of sharesValue(Rs in cr)
Domestic EquitiesSun Pharmaceutical Industries Limited11.93706256349997.5748
Domestic EquitiesDivi's Laboratories Limited7.33721000031613.1690
Domestic EquitiesCipla Limited6.08603200000508.6080
Domestic EquitiesLupin Limited6.08582683991508.5895
Domestic EquitiesApollo Hospitals Enterprise Limited5.9080648795493.7330
Domestic EquitiesDr. Reddy's Laboratories Limited5.90483916074493.4645
Domestic EquitiesMedPlus Health Services Limited3.65443627277305.3986
Domestic EquitiesVijaya Diagnostic Centre Limited3.48112886684290.9200
Domestic EquitiesGlaxoSmithKline Pharmaceuticals Limited3.0433913226254.3334
Domestic EquitiesGland Pharma Limited2.95731320549247.1407
Domestic EquitiesAjanta Pharma Limited2.8441959323237.6819
Domestic EquitiesThyrocare Technologies Limited2.62511733833219.3819
Domestic EquitiesAbbott India Limited2.587068677216.1952
Domestic EquitiesSai Life Sciences Limited2.52212555745210.7723
Domestic EquitiesDr. Lal Path Labs Limited2.4117609112201.5491
Domestic EquitiesZydus Lifesciences Limited2.34862000632196.2720
Domestic EquitiesMankind Pharma Limited2.2401757496187.2076
Domestic EquitiesNarayana Hrudayalaya Limited2.15991029215180.5037
Domestic EquitiesAurobindo Pharma Limited2.09421702630175.0133
Domestic EquitiesJB Chemicals & Pharmaceuticals Limited2.0626999649172.3695
Domestic EquitiesAlkem Laboratories Limited2.0541323678171.6626
Domestic EquitiesPfizer Limited1.9635318249164.0892
Domestic EquitiesBiocon Limited1.76174226436147.2279
Domestic EquitiesSanofi India Limited1.4174230272118.4519
Domestic EquitiesSuraksha Diagnostic Limited1.39083896349116.2281
Domestic EquitiesSanofi Consumer Healthcare India Limited1.3257213659110.7907
Domestic EquitiesIPCA Laboratories Limited1.3011785412108.7324
Domestic EquitiesTorrent Pharmaceuticals Limited1.2922303364107.9915
Domestic EquitiesFortis Healthcare Limited1.20401103889100.6195
Domestic EquitiesAnthem Biosciences Limited1.0361105850386.5908
Domestic EquitiesSyngene International Limited0.9590128049280.1460
Domestic EquitiesAkums Drugs and Pharmaceuticals Limited0.8236151526468.8309
Domestic EquitiesEmcure Pharmaceuticals Limited0.784147027265.5277
Domestic EquitiesAstraZeneca Pharma India Limited0.63346256852.9357
Domestic EquitiesIndoco Remedies Limited0.5854183492448.9191
Domestic EquitiesOrchid Pharma Limited0.432849272736.1686
Domestic EquitiesConcord Biotech Limited0.224911173818.7910
Total 99.4801 8313.5816
Cash & Cash Equivalents and Net AssetsTriparty Repo0.4120 34.4301
Cash & Cash Equivalents and Net AssetsNet Current Assets0.1074 8.9748
Cash & Cash Equivalents and Net AssetsCash Margin - CCIL0.0005 0.0445
Total 0.5199 43.4494
 

Attention Investors : Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers / DP and Exchanges / Depository. Receive information of your transactions directly from Exchanges / Depository on your mobile/email at the end of the day .......... Issued in the interest of investors

KYC is one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

“No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application from to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.’

Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.